Fr. 199.00

Autoimmune Thrombocytopenia

English · Paperback / Softback

Shipping usually within 6 to 7 weeks

Description

Read more

This book provides a concise yet comprehensive summary of the current state of knowledge concerning the pathophysiology, differential diagnosis and treatment options that support day-to-day patient management. It reviews a variety of treatments including TOP-R antagonists, along with Syk inhibitor, which has recently proven to be effective, enabling readers to update and broaden their knowledge of the disease.
Covering topics ranging from basic science to clinical practice, Autoimmune Thrombocytopenia will appeal to a wide readership, from medical interns and residents to clinicians and hematologists, offering them a thought-provoking, instructive and informative collection of cutting-edge works. Accordingly, readers will gain an overview of the autoimmune and other causes of the disease, and the book will serve as a foundation for new research directions that further our understanding of the pathophysiology and development of diagnosis and treatment options.p>

List of contents

Part 1    Introduction.-
1     Megakaryocytopoiesis and thrombocytopoisis
.-
Part 2    History.-
2     History.-

Part 3    Epidemiology.-
3     Epidemiology.-

Part 4    Pathophysiology.-
4     Platelet membrane glycoproteins.-
5     Autoantigens in ITP.-
6     T cell abnormalities.-

Part 5    Clinical manifestation.-
7     ITP in adults.-
8     ITP in childhood.-

Part 6    Diagnosis.-
9     Diagnosis in general.-
10    Differential Diagnosis: Secondary ITP.-
11    Differential Diagnosis: Hereditary thrombocytopenia.-
12    Differential Diagnosis: Aplastic thrombocytopenia.-

Part 7    Treatment of Adults.-
13    Helicobacter pylori (H. pylori) eradication.-
14    Steroid.-
15    High dose Immunnoglobulin.-
16    Splenectomy.-
17    Rituximab.-
18    TPO-R agonist.-
19    Others (Syk inhibitor and Other medications).-
20    Transfusion.-
21    Therapy in pregnancy.-

Part 8    Treatment of Children.-
22    Treatment of Children.

About the author










Editors:

Yoji Ishida: Iwate Medical University School of Medicine

Yoshiaki Tomiyama: Osaka University Hospital

Summary

This book provides a concise yet comprehensive summary of the current state of knowledge concerning the pathophysiology, differential diagnosis and treatment options that support day-to-day patient management. It reviews a variety of treatments including TOP-R antagonists, along with Syk inhibitor, which has recently proven to be effective, enabling readers to update and broaden their knowledge of the disease.

Covering topics ranging from basic science to clinical practice, Autoimmune Thrombocytopenia will appeal to a wide readership, from medical interns and residents to clinicians and hematologists, offering them a thought-provoking, instructive and informative collection of cutting-edge works. Accordingly, readers will gain an overview of the autoimmune and other causes of the disease, and the book will serve as a foundation for new research directions that further our understanding of the pathophysiology and development of diagnosis and treatment options.p>

Product details

Assisted by Yoj Ishida (Editor), Yoji Ishida (Editor), Tomiyama (Editor), Tomiyama (Editor), Yoshiaki Tomiyama (Editor)
Publisher Springer, Berlin
 
Languages English
Product format Paperback / Softback
Released 01.01.2018
 
EAN 9789811350603
ISBN 978-981-1350-60-3
No. of pages 229
Dimensions 155 mm x 11 mm x 235 mm
Weight 414 g
Illustrations X, 229 p. 26 illus., 7 illus. in color.
Subjects Natural sciences, medicine, IT, technology > Medicine > Non-clinical medicine

B, Medicine, INTERNAL MEDICINE, Hematology

Customer reviews

No reviews have been written for this item yet. Write the first review and be helpful to other users when they decide on a purchase.

Write a review

Thumbs up or thumbs down? Write your own review.

For messages to CeDe.ch please use the contact form.

The input fields marked * are obligatory

By submitting this form you agree to our data privacy statement.